Literature DB >> 26321437

The Burden of Cardiovascular Disease in Low- and Middle-Income Countries: Epidemiology and Management.

Ashna D K Bowry1, Jennifer Lewey2, Sagar B Dugani3, Niteesh K Choudhry3.   

Abstract

Cardiovascular disease (CVD) is the second leading cause of mortality worldwide, accounting for 17 million deaths in 2013. More than 80% of these cases were in low- and middle-income countries (LMICs). Although the risk factors for the development of CVD are similar throughout the world, the evolving change in lifestyle and health behaviours in LMICs-including tobacco use, decreased physical activity, and obesity-are contributing to the escalating presence of CVD and mortality. Although CVD mortality is falling in high-income settings because of more effective preventive and management programs, access to evidence-based interventions for combating CVD in resource-limited settings is variable. The existing pressures on both human and financial resources impact the efforts of controlling CVD. The implementation of emerging innovative interventions to improve medication adherence, introducing m-health programs, and decentralizing the management of chronic diseases are promising methods to reduce the burden of chronic disease management on such fragile health care systems.
Copyright © 2015 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26321437     DOI: 10.1016/j.cjca.2015.06.028

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  58 in total

1.  Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon.

Authors:  N Abdel Rida; M I Mohamed Ibrahim; Z U D Babar
Journal:  BMC Health Serv Res       Date:  2019-12-18       Impact factor: 2.655

2.  Household air pollution from wood-burning cookstoves and C-reactive protein among women in rural Honduras.

Authors:  Megan L Benka-Coker; Maggie L Clark; Sarah Rajkumar; Bonnie N Young; Annette M Bachand; Robert D Brook; Tracy L Nelson; John Volckens; Stephen J Reynolds; Ander Wilson; Christian L'Orange; Nicholas Good; Casey Quinn; Kirsten Koehler; Sebastian Africano; Anibal B Osorto Pinel; David Diaz-Sanchez; Lucas Neas; Jennifer L Peel
Journal:  Int J Hyg Environ Health       Date:  2022-03-05       Impact factor: 5.840

3.  Lipoprotein(a) Elevation: A New Diagnostic Code with Relevance to Service Members and Veterans.

Authors:  Renata J M Engler; Emily Brede; Todd Villines; Marina N Vernalis
Journal:  Fed Pract       Date:  2019-11

4.  The impact of diabetes mellitus and hypertension on clinical outcomes in a population of Iranian patients who underwent percutaneous coronary intervention: A retrospective cohort study.

Authors:  Mohammad Javad Zibaeenezhad; Seyyed Saeed Mohammadi; Mehrab Sayadi; Soorena Khorshidi; Ehsan Bahramali; Iman Razeghian-Jahromi
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09-25       Impact factor: 3.738

Review 5.  Understanding the rise of cardiometabolic diseases in low- and middle-income countries.

Authors:  J Jaime Miranda; Tonatiuh Barrientos-Gutiérrez; Camila Corvalan; Adnan A Hyder; Maria Lazo-Porras; Tolu Oni; Jonathan C K Wells
Journal:  Nat Med       Date:  2019-11-07       Impact factor: 53.440

Review 6.  Fixed-dose combination therapy to reduce the growing burden of cardiovascular disease in low- and middle-income countries: feasibility and challenges.

Authors:  Jobert Richie Nansseu; Aurel T Tankeu; Joseph Kamtchum-Tatuene; Jean Jacques Noubiap
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-06       Impact factor: 3.738

7.  Efficacy of Probiotic Milk Formula on Blood Lipid and Intestinal Function in Mild Hypercholesterolemic Volunteers: A Placebo-control, Randomized Clinical Trial.

Authors:  Hui-Fang Chiu; Chia-Yuan Fang; You-Cheng Shen; Kamesh Venkatakrishnan; Chin-Kun Wang
Journal:  Probiotics Antimicrob Proteins       Date:  2021-01-06       Impact factor: 4.609

8.  Cardiovascular disease (CVD): assessment, prediction and policy implications.

Authors:  Shazia Rehman; Erum Rehman; Muhammad Ikram; Zhang Jianglin
Journal:  BMC Public Health       Date:  2021-07-02       Impact factor: 3.295

9.  Geographic and Sociodemographic Disparities in Cardiovascular Risk in Burkina Faso: Findings from a Nationwide Cross-Sectional Survey.

Authors:  Kadari Cisse; Sekou Samadoulougou; Mady Ouedraogo; Bruno Bonnechère; Jean-Marie Degryse; Seni Kouanda; Fati Kirakoya-Samadoulougou
Journal:  Risk Manag Healthc Policy       Date:  2021-07-07

10.  Evaluation of a digitally enhanced cardiac auscultation learning method: a controlled study.

Authors:  Fred-Cyrille Goethe Doualla; Georges Bediang; Chris Nganou-Gnindjio
Journal:  BMC Med Educ       Date:  2021-07-12       Impact factor: 2.463

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.